Works matching Glucagon

Results: 5000

The mechanism of glucagon-induced natriuresis in dogs.

Published in:

Kidney International, 1972, v. 2, n. 1, p. 76, doi. 10.1038/ki.1972.74

By:

Levy, Mortimer;
Starr, Neil L.

Publication type:

Article

ABERRANT EXPRESSION OF GLUCAGON RECEPTORS IN ADRENAL GLANDS OF A PATIENT WITH CUSHING'S SYNDROME AND ACTH-INDEPENDENT MACRONODULAR ADRENAL HYPERPLASIA.

Published in:

Medicina (Buenos Aires), 2010, v. 70, n. 3, p. 254

By:

De Miguel, Valeria;
Ana Redal, Maria;
Lorena Viale, Maria;
Kahan, Mariano;
Glerean, Mariela;
Beskow, Axel;
Fainstein Day, Patricia

Publication type:

Article

Co-agonist of glucagon and GLP-1 reduces cholesterol and improves insulin sensitivity independent of its effect on appetite and body weight in diet-induced obese C57 mice.

Published in:

Canadian Journal of Physiology & Pharmacology, 2013, v. 91, n. 12, p. 1009, doi. 10.1139/cjpp-2013-0189

By:

Patel, Vishal;
Joharapurkar, Amit;
Dhanesha, Nirav;
Kshirsagar, Samadhan;
Patel, Kartik;
Bahekar, Rajesh;
Shah, Gaurang;
Jain, Mukul

Publication type:

Article

Glucagon Receptors: Effect of Exercise and Fasting.

Published in:

Canadian Journal of Applied Physiology, 2005, v. 30, n. 3, p. 313, doi. 10.1139/h05-124

By:

Lavoie, Carole

Publication type:

Article

Uso de los agonistas del receptor del péptido similar al glucagón tipo 1 en pacientes trasplantados renales.

Published in:

Nefrologia, 2024, v. 44, n. 6, p. 885, doi. 10.1016/j.nefro.2023.06.010

By:

Alberto Vigara, Luis;
Villanego, Florentino;
Orellana, Cristhian;
Eady, Myriam;
Sánchez, María Gabriela;
Alonso, Marta;
García, María Belén;
Manuel Amaro, José;
García, Teresa;
Mazuecos, Auxiliadora

Publication type:

Article

Phase I studies of the safety, tolerability, pharmacokinetics and pharmacodynamics of the dual glucagon receptor/glucagon‐like peptide‐1 receptor agonist BI 456906.

Published in:

Diabetes, Obesity & Metabolism, 2023, v. 25, n. 4, p. 1011, doi. 10.1111/dom.14948

By:

Jungnik, Arvid;
Arrubla Martinez, Jorge;
Plum‐Mörschel, Leona;
Kapitza, Christoph;
Lamers, Daniela;
Thamer, Claus;
Schölch, Corinna;
Desch, Michael;
Hennige, Anita M.

Publication type:

Article

Amino acids are sensitive glucagon receptor‐specific biomarkers for glucagon‐like peptide‐1 receptor/glucagon receptor dual agonists.

Published in:

Diabetes, Obesity & Metabolism, 2020, v. 22, n. 12, p. 2437, doi. 10.1111/dom.14173

By:

Li, Wenyu;
Kirchner, Thomas;
Ho, George;
Bonilla, Fany;
D'Aquino, Katharine;
Littrell, James;
Zhang, Rui;
Jian, Wenying;
Qiu, Xi;
Zheng, Songmao;
Gao, Bin;
Wong, Peggy;
Leonard, James N.;
Camacho, Raul C.

Publication type:

Article

Dual glucagon‐like peptide‐1 receptor/glucagon receptor agonist SAR425899 improves beta‐cell function in type 2 diabetes.

Published in:

Diabetes, Obesity & Metabolism, 2020, v. 22, n. 4, p. 640, doi. 10.1111/dom.13939

By:

Visentin, Roberto;
Schiavon, Michele;
Göbel, Britta;
Riz, Michela;
Cobelli, Claudio;
Klabunde, Thomas;
Dalla Man, Chiara

Publication type:

Article

Glucagon-like Peptide 1, Glucose-Dependent Insulinotropic Polypeptide, and Glucagon Receptor Agonists in Metabolic Dysfunction-Associated Steatotic Liver Disease: Novel Medication in New Liver Disease Nomenclature.

Published in:

International Journal of Molecular Sciences, 2024, v. 25, n. 7, p. 3832, doi. 10.3390/ijms25073832

By:

Chrysavgis, Lampros G.;
Kazanas, Spyridon;
Bafa, Konstantina;
Rozani, Sophia;
Koloutsou, Maria-Evangelia;
Cholongitas, Evangelos

Publication type:

Article

Cell‐specific resetting of mouse islet cellular clocks by glucagon, glucagon‐like peptide 1 and somatostatin.

Published in:

Acta Physiologica, 2018, v. 222, n. 4, p. 1, doi. 10.1111/apha.13021

By:

Petrenko, V.;
Dibner, C.

Publication type:

Article

Glucagon Can Increase Force of Contraction via Glucagon Receptors in the Isolated Human Atrium.

Published in:

International Journal of Molecular Sciences, 2025, v. 26, n. 2, p. 698, doi. 10.3390/ijms26020698

By:

Neumann, Joachim;
Schmidt, Franziska;
Hofmann, Britt;
Gergs, Ulrich

Publication type:

Article

Modulation of the Glucagon-dependent Induction of Phosphoeno/pyruvate Carboxykinase by Adenosine, but not Ketone Bodies or Ammonia in Rat Hepatocyte Cultures.

Published in:

Biological Chemistry, 1987, v. 368, n. 2, p. 1579

By:

CHRIST, Bruno;
LÖHNE, Rudolf;
SCHMIDT, Helga;
JUNGERMANN, Kurt

Publication type:

Article

The Change in Glucagon Following Meal Ingestion Is Associated with Glycemic Control, but Not with Incretin, in People with Diabetes.

Published in:

Journal of Clinical Medicine, 2021, v. 10, n. 11, p. 2487, doi. 10.3390/jcm10112487

By:

Yoo, Soyeon;
Kim, Dongkyu;
Koh, Gwanpyo

Publication type:

Article

Survodutide, a glucagon receptor/glucagon‐like peptide‐1 receptor dual agonist, improves blood pressure in adults with obesity: A post hoc analysis from a randomized, placebo‐controlled, dose‐finding, phase 2 trial.

Published in:

Diabetes, Obesity & Metabolism, 2025, v. 27, n. 2, p. 993, doi. 10.1111/dom.16052

By:

le Roux, Carel W.;
Steen, Oren;
Lucas, Kathryn J.;
Ekinci, Elif I.;
Startseva, Elena;
Unseld, Anna;
Hussain, Samina Ajaz;
Hennige, Anita M.

Publication type:

Article

A randomized Phase I study of the safety, tolerability, pharmacokinetics and pharmacodynamics of BI 456906, a dual glucagon receptor/glucagon‐like peptide‐1 receptor agonist, in healthy Japanese men with overweight/obesity.

Published in:

Diabetes, Obesity & Metabolism, 2023, v. 25, n. 7, p. 1973, doi. 10.1111/dom.15064

By:

Yazawa, Rie;
Ishida, Masahiro;
Balavarca, Yesilda;
Hennige, Anita M.

Publication type:

Article

Antiobesity therapeutics with complementary dual‐agonist activities at glucagon and glucagon‐like peptide 1 receptors.

Published in:

Diabetes, Obesity & Metabolism, 2022, v. 24, n. 1, p. 50, doi. 10.1111/dom.14546

By:

Park, Bong Gyu;
Kim, Gyeong Min;
Lee, Hye‐Jin;
Ryu, Jae Ha;
Kim, Dong‐Hoon;
Seong, Jae‐Young;
Kim, Soojeong;
Park, Zee‐Yong;
Kim, Young‐Joon;
Lee, Jaemin;
Kim, Jae Il

Publication type:

Article

Pharmacokinetics, safety, tolerability and efficacy of cotadutide, a glucagon‐like peptide‐1 and glucagon receptor dual agonist, in phase 1 and 2 trials in overweight or obese participants of Asian descent with or without type 2 diabetes.

Published in:

Diabetes, Obesity & Metabolism, 2021, v. 23, n. 8, p. 1859, doi. 10.1111/dom.14412

By:

Asano, Michiko;
Sekikawa, Akiko;
Kim, Hyosung;
Gasser, Robert A.;
Robertson, Darren;
Petrone, Marcella;
Jermutus, Lutz;
Ambery, Philip

Publication type:

Article

Improved postprandial glucose metabolism in type 2 diabetes by the dual glucagon‐like peptide‐1/glucagon receptor agonist SAR425899 in comparison with liraglutide.

Published in:

Diabetes, Obesity & Metabolism, 2021, v. 23, n. 8, p. 1795, doi. 10.1111/dom.14394

By:

Schiavon, Michele;
Visentin, Roberto;
Göbel, Britta;
Riz, Michela;
Cobelli, Claudio;
Klabunde, Thomas;
Dalla Man, Chiara

Publication type:

Article

Regulation of glucagon secretion by incretins.

Published in:

Diabetes, Obesity & Metabolism, 2011, v. 13, p. 89, doi. 10.1111/j.1463-1326.2011.01452.x

By:

Holst, J. J.;
Christensen, M.;
Lund, A.;
de Heer, J.;
Svendsen, B.;
Kielgast, U.;
Knop, F. K.

Publication type:

Article

The role of dysregulated glucagon secretion in type 2 diabetes.

Published in:

Diabetes, Obesity & Metabolism, 2011, v. 13, p. 126, doi. 10.1111/j.1463-1326.2011.01449.x

By:

D'Alessio, D.

Publication type:

Article

Effect of meal composition on postprandial glucagon-like peptide-1, insulin, glucagon, C-peptide, and glucose responses in overweight/obese subjects.

Published in:

European Journal of Nutrition, 2017, v. 56, n. 3, p. 1053, doi. 10.1007/s00394-016-1154-8

By:

Shah, Meena;
Franklin, Brian;
Adams-Huet, Beverley;
Mitchell, Joel;
Bouza, Brooke;
Dart, Lyn;
Phillips, Melody

Publication type:

Article

Glucagon Receptor Modulation: Its Role in Diabetes Care.

Published in:

Journal of Diabetology: Official Journal of Diabetes in Asia Study Group, 2023, v. 14, p. S47, doi. 10.4103/jod.jod_106_23

By:

Seshadri, Krishna G.;
Sosale, Aravind R.;
Kumar, Kanakatte M. Prasanna;
Reddy, Sanjay C.;
Chawla, Purvi

Publication type:

Article

Glucagon-Like Peptide-1 Based Therapies: A New Horizon in Obesity Management.

Published in:

Endocrinology & Metabolism, 2024, v. 39, n. 2, p. 206, doi. 10.3803/EnM.2024.1940

By:

Jang Won Son;
Soo Lim

Publication type:

Article

The Road towards Triple Agonists: Glucagon-Like Peptide 1, Glucose-Dependent Insulinotropic Polypeptide and Glucagon Receptor - An Update.

Published in:

Endocrinology & Metabolism, 2024, v. 39, n. 1, p. 12, doi. 10.3803/EnM.2024.1942

By:

Jakubowska, Agnieszka;
le Roux, Carel W.;
Viljoen, Adie

Publication type:

Article

Glucagon-Like Peptide-1 and Hypothalamic Regulation of Satiation: Cognitive and Neural Insights from Human and Animal Studies.

Published in:

Diabetes & Metabolism Journal, 2025, v. 49, n. 3, p. 333, doi. 10.4093/dmj.2025.0106

By:

Joon Seok Park;
Kyu Sik Kim;
Hyung Jin Choi

Publication type:

Article

A newly developed glucagon sandwich ELISA is useful for more accurate glucagon evaluation than the currently used sandwich ELISA in subjects with elevated plasma proglucagon‐derived peptide levels.

Published in:

Journal of Diabetes Investigation, 2023, v. 14, n. 5, p. 648, doi. 10.1111/jdi.13986

By:

Kobayashi, Masaki;
Maruyama, Nobuhiro;
Yamamoto, Yukako;
Togawa, Takeshi;
Ida, Takanori;
Yoshida, Morikatsu;
Miyazato, Mikiya;
Kitada, Masahisa;
Hayashi, Yoshitaka;
Kashiwagi, Atsunori;
Kitamura, Tadahiro

Publication type:

Article

Insulin–glucagon‐like peptide‐1 receptor agonist relay and glucagon‐like peptide‐1 receptor agonist first regimens in individuals with type 2 diabetes: A randomized, open‐label trial study.

Published in:

Journal of Diabetes Investigation, 2022, v. 13, n. 6, p. 965, doi. 10.1111/jdi.13749

By:

Takeshita, Yumie;
Kita, Yuki;
Tanaka, Takeo;
Goto, Hisanori;
Nakano, Yujiro;
Teramura, Chisato;
Enyama, Yasufumi;
Takamura, Toshinari;
Kaikoi, Yuka;
Yamamoto, Reina;
Nakagawa, Hiromi;
Asano, Shoko;
Funasaki, Yuka;
Igawa, Hirobumi;
Sako, Saori;
Yonezawa, Makoto;
Shima, Kosuke Robert;
Kurita, Seiichiro;
Nagaoka, Tadasu;
Shimizu, Akiko

Publication type:

Article

Association of glucagon‐like peptide‐1 receptor‐targeted imaging probe with in vivo glucagon‐like peptide‐1 receptor agonist glucose‐lowering effects.

Published in:

Journal of Diabetes Investigation, 2020, v. 11, n. 6, p. 1448, doi. 10.1111/jdi.13281

By:

Murakami, Takaaki;
Fujimoto, Hiroyuki;
Fujita, Naotaka;
Hamamatsu, Keita;
Yabe, Daisuke;
Inagaki, Nobuya

Publication type:

Article

Finerenone attenuates downregulation of the kidney GLP-1 receptor and glucagon receptor and cardiac GIP receptor in mice with comorbid diabetes.

Published in:

Diabetology & Metabolic Syndrome, 2024, v. 16, n. 1, p. 1, doi. 10.1186/s13098-024-01525-3

By:

Tran, Duc Tin;
Yeung, Emily S. H.;
Hong, Lisa Y. Q.;
Kaur, Harmandeep;
Advani, Suzanne L.;
Liu, Youan;
Syeda, Madiha Zahra;
Batchu, Sri Nagarjun;
Advani, Andrew

Publication type:

Article

Review of glucagon‐like peptide‐1 receptor agonists for the treatment of type 2 diabetes mellitus in patients with chronic kidney disease and their renal effects.

Published in:

Journal of Diabetes, 2019, v. 11, n. 12, p. 938, doi. 10.1111/1753-0407.12969

By:

Sloan, Lance A.

Publication type:

Article

Use of glucagon in severe hypoglycemia is scarce in most countries, and has not been expanded by new ready-to-use glucagons.

Published in:

Diabetology & Metabolic Syndrome, 2022, v. 14, n. 1, p. 1, doi. 10.1186/s13098-022-00950-6

By:

Pontiroli, Antonio E.;
Rizzo, Manfredi;
Tagliabue, Elena

Publication type:

Article

Glucagon and Its Receptors in the Mammalian Heart.

Published in:

International Journal of Molecular Sciences, 2023, v. 24, n. 16, p. 12829, doi. 10.3390/ijms241612829

By:

Neumann, Joachim;
Hofmann, Britt;
Dhein, Stefan;
Gergs, Ulrich

Publication type:

Article

Healthcare professionals' perceptions and management of obesity & knowledge of glucagon, GLP‐1, GIP receptor agonists, and dual agonists.

Published in:

Obesity Science & Practice, 2024, v. 10, n. 3, p. 1, doi. 10.1002/osp4.756

By:

Garvey, W. Timothy;
Mahle, Cathy D.;
Bell, Trevor;
Kushner, Robert F.

Publication type:

Article

Secretion of glucagon, GLP-1 and GIP may be affected by circadian rhythm in healthy males.

Published in:

BMC Endocrine Disorders, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12902-024-01566-9

By:

Zilstorff, Dorte B.;
Richter, Michael M.;
Hannibal, Jens;
Jørgensen, Henrik L.;
Sennels, Henriette P.;
Wewer Albrechtsen, Nicolai J.

Publication type:

Article

Glucagon-like peptide-1 receptor agonists in type 2 diabetes treatment: are they all the same?

Published in:

2019

By:

Gentilella, Raffaella;
Pechtner, Valeria;
Corcos, Antonella;
Consoli, Agostino

Publication type:

journal article

Glucagon for hypoglycemic episodes in insulin-treated diabetic patients: a systematic review and meta-analysis with a comparison of glucagon with dextrose and of different glucagon formulations.

Published in:

Acta Diabetologica, 2015, v. 52, n. 2, p. 405, doi. 10.1007/s00592-014-0665-0

By:

Boido, Augusto;
Ceriani, Valerio;
Pontiroli, Antonio

Publication type:

Article

Glucagon-like peptide-1 and glucagon-like peptide-1 receptor agonists in the treatment of type 2 diabetes.

Published in:

Annals of Pediatric Endocrinology & Metabolism, 2017, v. 22, n. 1, p. 15, doi. 10.6065/apem.2017.22.1.15

By:

Seungah Lee;
Dong Yun Lee

Publication type:

Article

Anti-inflammatory and antinociceptive activities of glucagon-like peptides: evaluation of their actions on serotonergic, nitrergic, and opioidergic systems.

Published in:

Psychopharmacology, 2019, v. 236, n. 6, p. 1717, doi. 10.1007/s00213-018-5154-7

By:

Aykan, Duygun Altıntaş;
Kesim, Murat;
Ayan, Beyza;
Kurt, Ayşegül

Publication type:

Article

Role of Glucagon and Its Receptor in the Pathogenesis of Diabetes.

Published in:

Frontiers in Endocrinology, 2022, v. 13, p. 1, doi. 10.3389/fendo.2022.928016

By:

Jia, Yunbo;
Liu, Yang;
Feng, Linlin;
Sun, Siyu;
Sun, Guangwei

Publication type:

Article

Concurrent Use of Teneligliptin and Canagliflozin Improves Glycemic Control with Beneficial Effects on Plasma Glucagon and Glucagon-Like Peptide-1: A Single-Arm Study.

Published in:

Diabetes Therapy, 2019, v. 10, n. 5, p. 1835, doi. 10.1007/s13300-019-0666-7

By:

Noda, Tomoho;
Ebihara, Emi;
Ueno, Hiroaki;
Sadohara, Keisuke;
Tanaka, Yuri;
Nagatomo, Yuuma;
Murakami, Yousuke;
Yonamine, Shinichi;
Tsuchimochi, Wakaba;
Sakoda, Hideyuki;
Yamaguchi, Hideki;
Nakazato, Masamitsu

Publication type:

Article

Pharmacotherapy for Type 2 Diabetes Mellitus: What's Up and Coming in the Glucagon-Like Peptide-1 (GLP-1) Pipeline?

Published in:

Journal of Pharmacy Practice, 2023, v. 36, n. 2, p. 418, doi. 10.1177/08971900211049032

By:

Elder, Mary J.;
Ashjian, Emily J.

Publication type:

Article

Mathematical Model of Glucagon Kinetics for the Assessment of Insulin-Mediated Glucagon Inhibition During an Oral Glucose Tolerance Test.

Published in:

Frontiers in Endocrinology, 2021, v. 11, p. N.PAG, doi. 10.3389/fendo.2021.611147

By:

Morettini, Micaela;
Burattini, Laura;
Göbl, Christian;
Pacini, Giovanni;
Ahrén, Bo;
Tura, Andrea

Publication type:

Article

Glucagon Shows Higher Sensitivity than Insulin to Grapeseed Proanthocyanidin Extract (GSPE) Treatment in Cafeteria-Fed Rats.

Published in:

Nutrients, 2021, v. 13, n. 4, p. 1084, doi. 10.3390/nu13041084

By:

Grau-Bové, Carme;
Ginés, Iris;
Beltrán-Debón, Raúl;
Terra, Ximena;
Blay, MTeresa;
Pinent, Montserrat;
Ardévol, Anna;
Amedei, Amedeo

Publication type:

Article

GLUCAGON-LIKE PEPTIDE 1: BIOCHEMISTRY, SECRETION AND MAIN PHYSIOLOGICAL EFFECTS.

Published in:

Revista da Faculdade de Ciências da Saúde, 2009, v. 6, p. 104

By:

Silva, Amélia M.;
Lopes, Carla Martins;
Misler, Stanley;
Cooper, Gregory D.;
Andreani, Tatiana;
Souto, Eliana B.

Publication type:

Article

Plasticity in the Glucagon Interactome Reveals Novel Proteins That Regulate Glucagon Secretion in α-TC1-6 Cells.

Published in:

Frontiers in Endocrinology, 2019, p. N.PAG, doi. 10.3389/fendo.2018.00792

By:

Asadi, Farzad;
Dhanvantari, Savita

Publication type:

Article

Glucagon-like peptide-2 inhibits antral emptying in man, but is not as potent as glucagon-like peptide-1.

Published in:

Scandinavian Journal of Gastroenterology, 2004, v. 39, n. 4, p. 353, doi. 10.1080/00365520410004424

By:

Nagell, C. F.;
Wettergren, A.;
Pedersen, J. F.;
Mortensen, D.;
Holst, J. J.

Publication type:

Article

Glukagon i białka glukagonopodobne i ich rola w metabolizmie glukozy. Część I.

Published in:

Pediatric Endocrinology, Diabetes & Metabolism, 2011, v. 17, n. 4, p. 215

By:

Otto-Buczkowska, Ewa

Publication type:

Article

Glucagon and glucagon‐like peptide‐1 dual agonist therapy: A possible future towards fatty kidney disease.

Published in:

European Journal of Clinical Investigation, 2025, v. 55, n. 1, p. 1, doi. 10.1111/eci.14330

By:

Kanbay, Mehmet;
Copur, Sidar;
Guldan, Mustafa;
Ozbek, Lasin;
Mallamaci, Francesca;
Zoccali, Carmine

Publication type:

Article

Relationship between metabolic syndrome and meal-induced glucagon like peptide-1 response in type 1 diabetic patients在1型糖尿病患者中代谢综合征与进餐诱导的胰高血糖素样肽-1应答之间的关系

Published in:

Journal of Diabetes, 2015, v. 7, n. 3, p. 340, doi. 10.1111/1753-0407.12194

By:

Blaslov, Kristina;
Bulum, Tomislav;
Zibar, Karin;
Duvnjak, Lea

Publication type:

Article

Weight loss effect of glucagon-like peptide-1 mimetics on obese/overweight adults without diabetes: A systematic review and meta-analysis of randomized controlled trials胰高血糖素样肽-1类似物对非糖尿病肥胖/超重成人的减重作用：一篇对随机对照试验进行的系统评价及meta分析

Published in:

Journal of Diabetes, 2015, v. 7, n. 3, p. 329, doi. 10.1111/1753-0407.12198

By:

Zhang, Fang;
Tong, YuZHen;
Su, Na;
Li, Yi;
Tang, LiZHi;
Huang, Li;
Tong, Nanwei

Publication type:

Article